Breast Biopsy Device Market Size, Share, Growth, Analysis, Trend, and Forecast Research Report by 2027 | Top Key Players Becton, Dickinson and Company, C.R. Bard, Inc.

May 04 17:01 2021
Breast Biopsy Device Market Size, Share, Growth, Analysis, Trend, and Forecast Research Report by 2027 | Top Key Players Becton, Dickinson and Company, C.R. Bard, Inc.
High prevalence of breast cancer, increasing awareness, innovative product launches, increasing strategic developments such as partnerships and agreements, favorable research funding scenario, reimbursement situations are key factors contributing to high CAGR of Breast Biopsy Device Market during forecast period.

The Breast Biopsy Device market is projected to grow at a rate of 10.8% in terms of value, from USD 0.65 Billion in 2019 to reach USD 1.51 Billion by 2027. Breast Biopsy refers to a diagnostic procedure to determine whether a small sample removed from the breast tissue is cancerous. It is regarded as the most effective methods for cancer diagnosis. It is found that about 70-80% of the biopsies are negative of cancer, but may diagnose conditions that are predispose to mammary carcinoma. Breast biopsy is recommended when a person is facing symptoms like a breast lump, sore breast, breast dimpling, peel appearance to breast and nipple discharge etc. The invasive surgical methods for breast biopsy has been found to be disadvantageous as it is painful and the patient will have to bear the psychological stress of false positive referrals.

Request a Sample Copy of the Research Report @

Leading Players Profiled in the Report Include:

Becton, Dickinson and Company, C.R. Bard, Inc., Devicor Medical Products Inc., Hologic Inc., Argon Medical Devices, Cook Medical Incorporated, Encapsule Medical Devices LLC, Planmed OY, and Ethicon Endo Surgery (Johnson and Johnson), among others.

The increasing vulnerability of women to mammary carcinoma in all the economies, along with the awareness drives and screenings conducted in favor of women have propelled the demand side of the breast biopsy market. The extensive and exhaustive research environment acts as an impetus to the market which has aided in evolving more accurate and minimally invasive methods for the early diagnosis of mammary carcinoma. The governments have also worked towards building a continuous and comprehensive environment for cancer research which has fueled the growth of these diagnostic devices. Also favorable reimbursements in this regard has improved the state of this market drastically. The growth of these diagnostic devices are impeded by the prevalence of side effects and infections after the biopsy. Stringent regulations by the USFDA and other notifying authorities along with high cost of these services have worked against the unrestricted growth of the market.

Further Key Finding from the report

  • The mammary carcinoma is found to be the most common invasive cancer among women and affects women in both developed and developing countries. Hence the target consumers for breast biopsy is women above the age of 40. The growing awareness of breast cancer has fueled the demand for this market
  • The American Cancer society has confirmed that there has been a decline in deaths caused by breast cancer reason being that cancer have been detected earlier through mammography, making it the most effective screening method
  • Thermography was popularized as it was a method to produce infrared images of head and blood flow near the surface of the body, but it was found that it lacked the ability to detect cancer at the early stage
  • Advancements and innovations are carried out in the product segment. Stryker, an innovator in the given field have brought in PreciseCore needles which have been used for improved precision and minimal tissue damage.
  • Currently the vacuum assisted breast biopsy has dominated over the market and is the fastest growing segment as it overcomes the drawbacks of the conventional needle based methods which is inherently characterized with inaccuracy. It is growing at a CAGR of 10.9%.
  • Key players involve themselves in the innovative product launch, market expansions and strategic acquisitions to capitalize their market share
  • As far as end users are concerned, hospitals are the second largest market share holder. This can be attributed to the availability of highly skilled personnel and favorable reimbursements
  • Ultra sound breast biopsy is considered to be the fastest growing as far as guidance of imaging is concerned. This is due to the accuracy in imaging and the lack of discomfort occurred during biopsy being non-invasive

Get Attractive Discount @

For the purpose of this study, Reports and Data have segmented the breast biopsy device market on the basis of type, product, guidance type, end-use, and region:

Type Outlook (Revenue, USD Million; 2017-2027)

  • Needle Breast Biopsy
    • Vacuum-Assisted Surgery
    • Core needle Biopsy
    • Fine Needle Aspiration Biopsy
  • Open Surgical Breast Biopsy
    • Incisional
    • Excisional

Product Outlook (Revenue, USD Million; 2017-2027)

  • Biopsy Needles
  • Biopsy Tables
  • Guidance Systems
  • Localization Wires
  • Punches
  • Markers
  • Sutures

Guidance Type Outlook (Revenue, USD Million; 2017-2027)

  • Mammography
  • Ultrasound
  • MRI
  • CT scan
  • Others

End-Use Outlook (Revenue, USD Million; 2017-2027)

  • Diagnostic Clinic
  • Hospitals
  • Others

Regional Outlook (Revenue, USD Million; 2017-2027)

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Benelux
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • MEA
    • Saudi Arabia
    • UAE
    • Rest of the Middle East and Africa

Request for Customization @

Table of contents            

Chapter 1. Market Synopsis

    1.1. Market Definition

    1.2. Research Scope & Premise

    1.3. Methodology

    1.4. Market Estimation Technique

Chapter 2. Executive Summary

    2.1. Summary Snapshot, 2018 – 2026

Chapter 3. Indicative Metrics

    3.1. Rising prevalence of breast cancer

    3.2. Awareness among women

    3.3. Introduction of non-invasive methods

    3.4. Regulations

Chapter 4. Breast Biopsy Device Segmentation & Impact Analysis

    4.1. Breast Biopsy Device Segmentation Analysis

    4.2. Breast Biopsy Device Market Value Chain Analysis, 2016-2026

    4.3. Regulatory framework

    4.4. Breast Biopsy Device Market Impact Analysis

         4.4.1. Market driver analysis

        High prevalence of breast cancer diseases across the world

        Minimally invasive techniques

        Product launch and technological advancement

         4.4.2. Market restraint analysis

        Lack of awareness among women


    4.5. Key opportunities prioritized

    4.6. Breast Biopsy Device Pricing Analysis

    4.7. Industry analysis – Porter’s

    4.8. Breast Biopsy Device PESTEL Analysis


Have Any Query? Ask Our Experts @

About Reports and Data                              

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Media Contact
Company Name: Reports and Data
Contact Person: John Watson
Email: Send Email
Phone: +1-212-710-1370
Address:40 Wall St. 28th floor
City: New York City
State: NY 10005
Country: United States